Canine parvo preventative gets full USDA approvalDecember 16, 2025The product, now approved as a therapeutic for canine parvovirus, marks the first USDA-approved treatment for the disease beyond supportive care and will be marketed under the name Trutect.
SPONSORED CONTENTIs your parasite protocol missing something?Adding Hill’s GI nutrition to your parasite protocol supports GI healing for more complete diarrhea management than medication alone. + Learn More
USDA approves parvo preventative for puppiesJune 27, 2025The conditional approval of the Canine Parvovirus Monoclonal Antibody (CPMA) for passive immunity allows veterinarians to protect exposed puppies from canine parvovirus.
5 Questions With…Hunter Finn, DVM, veterinarian-influencerSeptember 3, 2024Dr. Finn shares about the cases he sees in his practice, how he integrates the first USDA-conditionally approved Canine Parvovirus Monoclonal Antibody (CPMA) treatment to handle parvo cases, and his social media work.
Monoclonal antibody (mAb) product innovation aim of facility expansion in KansasAugust 23, 2024A $130-million investment through 2026 is expected to bolster production and development of monoclonal antibody-based therapy, including a potential product in canine dermatology.
